![Pearls in a shell](/media/hbmpartners/styles/hero_small/public/images/hero-images/hero-portfolio-companies.jpg?h=14832055&itok=DIQpNLis)
Ignis Therapeutics
Industry
CNS diseases
HBM contact
Company status
Private
Ignis Therapeutics is developing and commercializing in China a pipeline of CNS-focused products including FDA-approved cenobamate and solriamfetol.
![Logo Ignis Therapeutics](/media/hbmpartners/images/portfolio/logo/ignis.jpg)